## Abstract Peripheral blood lymphocytes from 20 patients with acute infectious mononucleosis (IM) were studied for cell aggregation and for cap formation by concanavalin A (Con A). The lymphocytes from these patients showed 5.2Β±1.5% cells with a ConβAβinduced cap and a high degree of cell aggregat
Elevation of soluble CD23 in sera from patients with infectious mononucleosis
β Scribed by Hashimoto, Shu; Takei, Masami; Gon, Yasuhiro; Sawada, Shigemasa; Maekawa, Naoko; Yodoi, Junji; Takada, Kenzo; Horie, Takashi
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 61 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
CD23 is induced in B cells upon infection by Epstein-Barr virus (EBV) and a soluble form (soluble CD23: sCD23) is found in culture supernatants from EBV-transformed B cell lines. Based on these observations, we measured serum sCD23 levels in patients with infectious mononucleosis (IM) caused by EBV infection. Sera from patients with IM at the time of diagnosis contained more sCD23 than sera from normal control subjects. Changes in serum sCD23 levels during the course of disease showed that serum sCD23 levels were elevated at the time of diagnosis and they decreased to the normal levels during the convalescent phase defined by the improvement of symptoms of IM. These results indicate that the elevated levels of sCD23 were observed at the acute phase of IM and may be useful in diagnosing IM.
π SIMILAR VOLUMES
## Abstract Suppressor/cytotoxic T cells express the surface marker CD8, which can be measured in a soluble form in culture supernatants of activated human lymphocytes. Using a sandwich immunoassay, we assessed the levels of soluble CD8 (sCD8) in serum from patients with rheumatoid arthritis (RA; n
## Abstract The presence of EpsteinβBarr virus (EBV) in the blood and urine of 20 patients with infectious mononucleosis (IM) was investigated together with the clinical course of the disease, and in 9 patients up to 2β7 months after recovery. EBV DNA, analyzed by the polymerase chain reaction (PCR
## Abstract Sera from infectious mononucleosis patients aged 2 to 35 years and from normal subjects aged 11 to 35 years were examined for the presence of antibody to the EB virus capsid antigen (VCA) in the indirect immunofluorescence test, and for the presence of antibody reactive with the soluble